Purdue Pharma Says It Will Cease Marketing OxyContin

Purdue Pharma, one of the largest manufacturers of Oxycontin in America, has vowed to stop marketing the opioid to doctors. Oxycontin is an opioid medication that has been on the market for over 20 years and is viewed by many addiction and law enforcement professionals to be the catalyst for America’s current opioid addiction crisis. It’s a common drug of abuse and is often responsible for overdoses. Purdue released a statement saying that it would no longer send sales representatives to market the opioid painkiller at doctor’s offices and that the Medical Affairs office will now handle all Oxycontin orders and queries. Many people involved in the addiction industry, the medical community and other public heatlh experts say it’s too little, too late. Purdue has long marketed Oxycontin as effective and safe for use, dropping off samples at the offices of practitioners and telling physicians that it was ideal for treating chronic pain. While these statements weren’t proven, medical marketing is an industry that often finds the loopholes. Purdue…

Continue Reading